Genetic polymorphisms within genes encoding immune checkpoints—particularly programmed cell death protein 1 (PD-1), its ligand PD-L1 and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)—have ...
Submissions open on 24 August 2026. The immune system relies on a complex network of receptor-ligand interactions to distinguish self from non-self, maintain immune tolerance, and mount effective ...
Time-resolved cardiovascular risk after immune checkpoint inhibitors: A large real-world cancer cohort study. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I. This abstract does ...
Interventions of the nurse navigator in the identification and management of toxicities after the start of treatment in patients with cancer using antineoplastic therapy. This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results